MedCity News November 20, 2024
Stephanie Baum

Personify Health Chief Medical Officer Jeff Jacques offers a window into companies’ strategies for including GLP-1 drugs in their health benefits.

At a time when self-insured employers are searching for ways to address escalating healthcare costs, the rise of GLP-1 drugs for weight loss poses some interesting questions for employers. Could investment in these pricey drugs as a health benefit stem the cost of chronic conditions in the long term? How do employers decide who should get access to these...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Insurance, Pharma / Biotech, Self-insured, Trends
Employer-Provider Direct Contracting: Practice And Policy
Elevance Health Bolsters Employer Insurance Business
Accolade Gets a Do-Over With Transcarent’s $621M Acquisition
Transcarent to buy Accolade for $621M
Transcarent to acquire fellow health benefits navigator Accolade for $621M

Share This Article